HomeVLA • VIE
add
Valneva SE
Previous close
€2.59
Day range
€2.60 - €2.64
Year range
€2.48 - €6.99
Market cap
422.79M EUR
Avg Volume
1.05K
P/E ratio
-
Dividend yield
-
Primary exchange
EPA
Market news
Financials
Income Statement
Revenue
Net income
| (EUR) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | 38.06M | -5.41% |
Operating expense | 110.47M | 137.29% |
Net income | -24.93M | -47.37% |
Net profit margin | -65.51 | -55.79% |
Earnings per share | -0.19 | 33.97% |
EBITDA | -107.68M | -406.60% |
Effective tax rate | 0.66% | — |
Balance Sheet
Total assets
Total liabilities
| (EUR) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 131.41M | -35.71% |
Total assets | 466.57M | -14.01% |
Total liabilities | 300.29M | -14.66% |
Total equity | 166.28M | — |
Shares outstanding | 131.55M | — |
Price to book | 2.06 | — |
Return on assets | -57.99% | — |
Return on capital | -72.36% | — |
Cash Flow
Net change in cash
| (EUR) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | -24.93M | -47.37% |
Cash from operations | -37.83M | 7.97% |
Cash from investing | 895.00K | 129.15% |
Cash from financing | -9.13M | -61.34% |
Net change in cash | -45.23M | 9.68% |
Free cash flow | -80.38M | -70.10% |
About
Valneva SE is a French biotech company headquartered in Saint-Herblain, France, developing and commercializing vaccines for infectious diseases. It has manufacturing sites in Livingston, Scotland; Solna, Sweden, and Vienna, Austria; with other offices in France, Canada and the United States. Wikipedia
Founded
2013
Website
Employees
700
